INTERNATIONAL PATENT: MEMORIAL SLOAN-KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH FILES APPLICATION FOR "ENGINEERED IMMUNE CELLS EXPRESSING ANTI-U5 SNRNP200 ANTIBODIES AND USES THEREOF"

GENEVA, April 15 -- MEMORIAL SLOAN-KETTERING CANCER CENTER (1275 York AvenueNew York, New York 10065), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (1275 York AvenueNew York, New York 10065), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1275 York AvenueNew York, New York 10065) filed a patent application (PCT/US2025/049381) for "ENGINEERED IMMUNE CELLS EXPRESSING ANTI-U5 SNRNP200 ANTIBODIES AND USES THEREOF" on Oct 03, 2025. With publication no. WO/2026/076325, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABDEL-W...